Skip to main content
TipRanks
Go Ultimate75% OFF

Fairchem Organics Ltd (FAIRCHEMOR) AI Stock Analysis

2 Followers
IN:FAIRCHEMOR

Fairchem Organics Ltd

(NSE:FAIRCHEMOR)

Select Model
Rating:50Neutral
Price Target:INR 660.00▼(-0.32% Downside)
Action:reiterated
Date:10/14/26

The overall score of 50 reflects a sharp conflict between poor fundamentals and strong market momentum. The company's financial performance is severely weakened by declining revenues and collapsing margins, and its valuation is extremely high with a P/E over 71. These factors are significant risks. However, the stock's price is being driven higher by powerful bullish technical momentum, trading above all key moving averages with strong MACD and RSI readings. The final score is a weighted compromise, heavily pulled down by the weak financial base and stretched valuation, but lifted by the current technical strength.

Positive Factors
Diversified Specialty Chemical PortfolioExposure to multiple end markets gives Fairchem Organics a broader demand base than a single-application producer. This diversification can support customer reach, reduce dependence on one sector, and create durable opportunities for specialty ingredient sales across domestic and export markets.
Negative Factors
Sharp Profitability DeteriorationVery low current margins and returns indicate that Fairchem Organics is converting its sales and equity base into substantially less profit than in prior years. Unless profitability recovers, weaker earnings power could constrain reinvestment, shareholder returns, and resilience through future cost or pricing pressure.

Fairchem Organics Ltd (FAIRCHEMOR) vs. iShares MSCI India ETF (INDA)

-40%-30%-20%-10%0%10%20%IN:FAIRCHEMOR-5.38%INDA-5.34%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 8.25B
Dividend Yield
0.15%
Average Volume (3M)
3,002
Price to Earnings (P/E)
35.4
Beta (1Y)
0.10
Revenue Growth
17.44%
EPS Growth
304.08%
Country
India
Employees
212
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Fairchem Organics Ltd Business Overview & Revenue Model

Company Description

Fairchem Organics Limited, headquartered in Ahmedabad, India, was founded in 2019. This company specializes in the manufacturing and worldwide sale of sophisticated oleochemicals and key nutraceutical components. Its market reach extends across India...

Fairchem Organics Ltd Financial Statement Overview

Summary

Financial health is under significant pressure. Revenue has declined for three consecutive years, gross margin collapsed to 7.7%, and net margin is a thin 1.2%. While the balance sheet has moderate leverage (D/E 0.32), return on equity is a very low 2.1%, and cash flow generation, though positive, is volatile and covers only 37% of total debt.

Income Statement

30Negative

Balance Sheet

40Negative

Cash Flow

35Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue5.60B4.60B5.38B6.21B6.47B6.42B
Gross Profit642.92M355.37M666.52M1.54B1.56B1.78B
EBITDA446.72M220.40M441.21M681.10M729.68M1.05B
Net Income237.76M55.41M219.74M405.00M435.01M679.06M
Balance Sheet
Total Assets3.98B3.91B4.02B3.34B3.42B3.24B
Cash, Cash Equivalents and Short-Term Investments14.24M12.26M12.86M84.00K838.00K83.00K
Total Debt702.35M837.82M630.32M73.18M501.68M620.30M
Total Liabilities1.17B1.28B997.98M443.77M831.48M919.26M
Stockholders Equity2.82B2.63B3.02B2.90B2.59B2.32B
Cash Flow
Free Cash Flow0229.13M-464.87M563.52M348.89M58.91M
Operating Cash Flow0382.54M-203.78M744.80M496.15M404.85M
Investing Cash Flow0-140.95M-255.71M-176.25M-144.92M-341.84M
Financing Cash Flow0-241.53M459.49M-568.55M-351.24M-63.19M

Fairchem Organics Ltd Technical Analysis

Technical Analysis SentimentNegative
Last Price662.15

Price Trends

50DMA681.98Negative
100DMA697.94Negative
200DMA638.73Positive

Market Momentum

MACD-9.07Positive
RSI44.34Neutral
STOCH33.23Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FAIRCHEMOR, the sentiment is Negative. The current price of 662.15 is below the 20-day moving average (MA) of 687.36, below the 50-day MA of 681.98, and above the 200-day MA of 638.73, indicating a neutral trend. The MACD of -9.07 indicates Positive momentum. The RSI at 44.34 is Neutral, neither overbought nor oversold. The STOCH value of 33.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:FAIRCHEMOR.

Fairchem Organics Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:FAIRCHEMOR against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:ALKYLAMINEIN:ALKYLAMINE71OutperformINR 82.34B33.20―0.62%13.38%35.82%
IN:ATULIN:ATUL68NeutralINR 149.64B19.38―0.59%18.15%42.38%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:JUBLINGREAIN:JUBLINGREA53NeutralINR 93.80B26.49―0.85%15.41%21.76%
IN:LXCHEMIN:LXCHEM53NeutralINR 42.83B24.88―0.19%21.34%105.39%
IN:FAIRCHEMORIN:FAIRCHEMOR50NeutralINR 8.34B35.38―0.15%17.44%304.08%
IN:AARTIINDIN:AARTIIND47NeutralINR 170.80B28.78―0.21%39.85%103.71%

* General Sector Average

Performance Comparison

-40%-20%0%20%IN:FAIRCHEMORIN:AARTIINDIN:ALKYLAMINEIN:ATULIN:JUBLINGREAIN:LXCHEMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:FAIRCHEMOR and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:FAIRCHEMORFairchem Organics Ltd662.15-34.40-4.94%
IN:AARTIINDAARTI Industries Ltd470.8581.3720.89%
IN:ALKYLAMINEAlkyl Amines Chemicals Limited1609.75-151.46-8.60%
IN:ATULAtul Limited5082.70-1021.02-16.73%
IN:JUBLINGREAJubilant Ingrevia Ltd.588.90-119.43-16.86%
IN:LXCHEMLaxmi Organic Industries Ltd.154.10-28.24-15.49%

Fairchem Organics Ltd Corporate Events

Fairchem Organics Confirms Full Demat Compliance Under SEBI Rules

Oct 7, 2026

Fairchem Organics Ltd has reported to the NSE and BSE that it has obtained the required confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The filing...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 14, 2026